Publication | Closed Access

Vascular endothelial growth factor improves the cognitive decline of Alzheimer’s disease via concurrently inducing the expression of ADAM10 and reducing the expression of β-site APP cleaving enzyme 1 in Tg2576 mice

Neurodegenerative DiseasesAlzheimer's DiseaseAgingMedicineVascular Cognitive Disorderβ-Site AppVascular DementiaDegenerative PathologyNeurologyNeuroscienceNeurodegenerationAging-associated DiseaseCognitive DeclineTg2576 Mice